EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble macrophage-mannose receptor, CD206 (sCD206): A new potential biomarker for idiopathic pulmonary fibrosis

Anne Juhl Nielsen, Thomas Skovhus Prior, Jesper Rømhild Davidsen, Nils Hoyer, Saher Burhan Shaker, Elisabeth Bendstrup, Holger Jon Møller

Immunobiology · 2026-11 · 231 (6) · 153263

DOI: 10.1016/j.imbio.2026.153263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunobiology, 2026-11. Verfasst von Anne Juhl Nielsen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim GmbH, TrygFonden, Aarhus University Department of Clinical Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Effective biomarkers for monitoring and predicting progression of idiopathic pulmonary fibrosis (IPF), a debilitating scarring lung disease, are currently insufficient. Markers of alternatively activated macrophages, and their soluble (s) forms in serum have been associated with various fibrotic diseases. In this study, we investigated the association of three macrophage biomarkers (sCD163, sCD206 and sSIRPα) with prognosis and clinical severity in patients with IPF. METHODS: Serum samples were collected from 149 IPF patients at baseline and after 12 and 36 months. Levels of sCD206, sCD163, and sSIRPα were quantified using enzyme-linked immunosorbent assays. RESULTS: Levels of sCD206, sCD163, and sSIRPα were stable and did not significantly increase over time. Contrary to sCD163 and sSIRPα, sCD206 demonstrated repeated significant correlations to routine biochemical parameters (positive correlation to lactate dehydrogenase, p = 0.010, and C-reactive protein, p = 0.000; negative correlation to albumin, p = 0.003, and haemoglobin, p = 0.014) at baseline. At baseline, higher levels of sCD206 were significantly associated with lower results for forced vital capacity, 6-min walk test distance, and more shortness of breath (p = 0.000, p = 0.018, and p = 0.020, respectively). By both unadjusted and adjusted Cox regression analysis, IPF patients with sCD206 levels >0.2815 mg/L had a significantly increased risk of dying (Hazard ratio (HR): 2.60 (95% CI 1.59-4.24), p < 0.001 and HR: 2.17 (95% CI 1.30-3.62), p = 0.003, respectively). CONCLUSION: sCD206 is associated with both IPF disease severity and mortality. The role of CD206+ macrophage function in IPF and the potential prognostic value of sCD206 should be further investigated.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersBloodEnzyme-linked Immuno AssaysIdiopathic pulmonary fibrosisLung fibrosisPulmonary diseasesPulmonary macrophages

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
  • Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark; Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark.
  • South Danish Center for Interstitial Lung Diseases (SCILS), Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark; Odense Respiratory Research Unit (ODIN), Department of Clinical Research, Univ…
  • Department of Respiratory Medicine, Herlev & Gentofte Hospital, Copenhagen, Denmark.
  • Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: holgmoel@rm.dk.

Förderung

  • Boehringer Ingelheim GmbH
  • TrygFonden
  • Aarhus University Department of Clinical Medicine
  • Frimodt Henike Foundation
  • Central Denmark Region Department for Regional Health
  • Danish Lung Association

Zitieren

APA

Nielsen, A. J., Prior, T. S., Davidsen, J. R., Hoyer, N., Shaker, S. B., Bendstrup, E., & Møller, H. J. (2026). Soluble macrophage-mannose receptor, CD206 (sCD206): A new potential biomarker for idiopathic pulmonary fibrosis. Immunobiology, 231(6), 153263. https://doi.org/10.1016/j.imbio.2026.153263

Vancouver

Nielsen AJ, Prior TS, Davidsen JR, Hoyer N, Shaker SB, Bendstrup E, et al. Soluble macrophage-mannose receptor, CD206 (sCD206): A new potential biomarker for idiopathic pulmonary fibrosis. Immunobiology. 2026;231(6):153263. doi:10.1016/j.imbio.2026.153263

BibTeX
@article{Nielsen2026,
  author = {Nielsen, Anne Juhl and Prior, Thomas Skovhus and Davidsen, Jesper Rømhild and Hoyer, Nils and Shaker, Saher Burhan and Bendstrup, Elisabeth and Møller, Holger Jon},
  title = {Soluble macrophage-mannose receptor, CD206 (sCD206): A new potential biomarker for idiopathic pulmonary fibrosis},
  journal = {Immunobiology},
  year = {2026},
  volume = {231},
  number = {6},
  pages = {153263},
  doi = {10.1016/j.imbio.2026.153263}
}
Kostenlos starten →